ACE and type 2 diabetes mellitus: The UK National Institute for Health and Care Excellence (NICE) recommends an ACE inhibitor as first-line antihypertensive in patients with type 2 diabetes with ARBs reserved for those in whom ACE inhibitors are not tolerated [21].